SCHEMBL24740260

SCHEMBL24740260

CCNC(=O)OCC1CCC(F)(F)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
EPHX1 P07099 1/20 0.40
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
NAAA Q02083 1/20 0.37
ASAH1 Q13510 1/20 0.37
SCN9A Q15858 5/20 0.36
SCN5A Q14524 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
EPHX2 P34913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13367965 0.84 EPHX1 (0.48) ALDH1A1MEN1KMT2AEPHX1CHRNB2
SCHEMBL24112751 0.83 PSEN1 (0.44) EPHX1CHRNB2CHRNA4NAAAASAH1
SCHEMBL8393587 0.81 EPHX1 (0.55) ALDH1A1MEN1KMT2AEPHX1CHRNB2
SCHEMBL24441491 0.81 EPHX1 (0.50) ALDH1A1MEN1KMT2AEPHX1CHRNB2
SCHEMBL23836198 0.81 NAAA (0.37) NAAAASAH1SCN9ASCN5APSEN1
SCHEMBL8393585 0.80 EPHX1 (0.58) ALDH1A1MEN1KMT2AEPHX1CHRNB2
SCHEMBL8392638 0.80 EPHX1 (0.58) ALDH1A1MEN1KMT2AEPHX1CHRNB2
SCHEMBL25846419 0.78 SCN9A (0.36) ALDH1A1NAAAASAH1SCN9ASCN5A
SCHEMBL27920617 0.77 NAAA (0.37) ALDH1A1NAAAASAH1SCN9ASCN5A
SCHEMBL13967719 0.77 EPHX1 (0.42) ALDH1A1MEN1KMT2AEPHX1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof Pardes Biosciences, Inc. (US) 2022-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof CTRL, CTSV, CTSL ALDH1A1 2252/4885MEN1 4164/4885KMT2A 3130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.